BlackThorn Therapeutics

About:

BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.

Website: http://www.blackthornrx.com/

Twitter/X: blackthornrx

Top Investors: Alexandria Real Estate Equities, Mercury, Google Ventures, Polaris Partners, Alexandria Venture Investments

Description:

BlackThorn Therapeutics operator of a clinical-stage biopharmaceutical company intended to develop precision medicine for disorders of the central nervous system (CNS) based on advances in computational and clinical neuroscience. The company leverages a deep understanding of brain and behavior relationships that seeks to overcome historic challenges in drug discovery and development by targeting dysfunctional brain circuits. Its proprietary computational platform, the company seeks to identify novel targets, small molecule drug candidates and biologically-based patient subgroups most likely to respond to treatment.

Total Funding Amount:

$138M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)blackthornrx.com

Founders:

Alex Tkachenko, Bill Martin, Ed Roberts

Number of Employees:

11-50

Last Funding Date:

2019-06-13

IPO Status:

Private

© 2024 MyAiNote.com